Treatment Experiences with CDK4&6 Inhibitors Among Women with Metastatic Breast Cancer: A Qualitative Study

Treatment Experiences with CDK4&6 Inhibitors Among Women with Metastatic Breast Cancer: A Qualitative Study

Judith J Stephenson,1 Jonathon Colby Gable,2 Rebekah Zincavage,1 Gregory L Price,2 Collin Churchill,2 Emily Zhu,2 Keri Stenger,2 Mukul Singhal,1 Bal Nepal,1 Michael Grabner,1 Michael J Fisch,3 David Debono,4 Amy R Geschwender,5 Gebra Cuyun Carter2 1HealthCore, Inc., Wilmington, DE, USA; 2Eli Lilly a...

Full description

Bibliographic Details
Main Authors: Stephenson JJ, Gable JC, Zincavage R, Price GL, Churchill C, Zhu E, Stenger K, Singhal M, Nepal B, Grabner M, Fisch MJ, Debono D, Geschwender AR, Cuyun Carter G
Format: Article
Language:English
Published: Dove Medical Press 2021-11-01
Series:Patient Preference and Adherence
Subjects:
oral oncolytics
patient perspective
semi-structured interviews
adherence
persistence
cdk4&6i users
Online Access:https://www.dovepress.com/treatment-experiences-with-cdk46-inhibitors-among-women-with-metastati-peer-reviewed-fulltext-article-PPA

Internet

https://www.dovepress.com/treatment-experiences-with-cdk46-inhibitors-among-women-with-metastati-peer-reviewed-fulltext-article-PPA

Similar Items